| Literature DB >> 27830830 |
Hiroaki Ikezaki1,2,3, Masumi Ai4, Ernst J Schaefer1, Seiko Otokozawa5, Bela F Asztalos1, Katsuyuki Nakajima6, Yanhua Zhou7, Ching-Ti Liu7, Paul F Jacques2, L Adrienne Cupples7, Norihiro Furusyo3.
Abstract
We compared markers of glucose homeostasis and their association with diabetes and impaired fasting glucose (IFG) in Fukuoka, Japanese subjects (n = 1108) and age-, gender- and menopausal status-matched participants in the Framingham Offspring Study (n = 1096). The markers examined included fasting glucose, insulin, adiponectin, and glycated albumin, as well as body mass index (BMI), use of medications, and history of diabetes. The results showed that IFG prevalence in Japanese men (15.9%) and women (7.4%) were 50% less than those observed in Framingham men (34.5%) and women (21.4%) (P < 0.001). However, the diabetes prevalence in Japanese men at 13.3% was twice as high (P < 0.01) as the rate in Framingham men at 6.5%, while these rates were similar in women. Median insulin levels in Japanese men (4.6 μIU/mL) and women (4.3 μIU/mL) were about 50% lower (P < 0.001) than those in Framingham men (10.8 μIU/mL) and women (9.9 μIU/mL), as were insulin resistance values (P < 0.001). These population differences were also observed after subjects were stratified by glucose levels. In conclusion, our data indicate that there is significantly less IFG, lower insulin levels, and insulin resistance, but higher diabetes prevalence in Fukuoka men than in Framingham men, indicating that insulin deficiency may be an important cause of diabetes in Japan.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27830830 PMCID: PMC5103215 DOI: 10.1038/srep36725
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Parameters in Women*.
*Data are shown as median values [25% quartile, 75% quartile values] and number (%).
BMI, body mass index; HOMA-IR, homeostasis model assessment of insulin resistance; HOMA-β, homeostasis model assessment of β cell function.
Parameters in Men*.
*Data are shown as median values [25% quartile, 75% quartile values] and number (%).
BMI, body mass index; HOMA-IR, homeostasis model assessment of insulin resistance; HOMA-β, homeostasis model assessment of β cell function.
Parameters in women by glucose homeostasis*.
*Data are shown as median values [25% quartile, 75% quartile values] and number (%).
NGT, normal glucose tolerance; IFG, impaired fasting glucose; BMI, body mass index; HOMA-IR, homeostasis model assessment of insulin resistance; HOMA-β, homeostasis model assessment of β cell function.
Parameters in men by glucose homeostasis*.
*Data are shown as median values [25% quartile, 75% quartile values] and number (%).
NGT, normal glucose tolerance; IFG, impaired fasting glucose; BMI, body mass index; HOMA-IR, homeostasis model assessment of insulin resistance; HOMA-β, homeostasis model assessment of β cell function.
Age- and BMI-adjusted multivariable logistic regression analysis for presence of diabetes classified by sex and population (model 1).
| Variables | Framingham | Fukuoka | ||
|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | |||
| Women | ||||
| Insulin (per 1 μiu/mL) | 1.12 (1.00–1.25) | 0.052 | 1.00 (0.96–1.03) | 0.85 |
| Adiponectin (per 1 μg/mL) | 0.89 (0.77–1.04) | 0.14 | 0.90 (0.81–1.00) | 0.04 |
| Glycated albumin (per 1%) | 2.62 (1.88–3.65) | <0.001 | 2.18 (1.69–2.81) | <0.001 |
| Men | ||||
| Insulin (per 1 μiu/mL) | 1.03 (0.95–1.11) | 0.49 | 1.11 (1.03–1.20) | <0.01 |
| Adiponectin (per 1 μg/mL) | 0.65 (0.49–0.86) | <0.01 | 0.97 (0.88–1.07) | 0.51 |
| Glycated albumin (per 1%) | 1.74 (1.39–2.17) | <0.001 | 2.00 (1.65–2.42) | <0.001 |
BMI, body mass index; OR, odds ratio; CI, confidential interval.
Age- and BMI-adjusted multivariable logistic regression analysis for presence of diabetes classified by sex and population (model 2).
| Variables | Framingham | Fukuoka | ||
|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | |||
| Women | ||||
| Insulin (per 1 μiu/mL) | 1.03 (0.96–1.10) | 0.48 | 1.01 (0.98–1.03) | 0.66 |
| Adiponectin (per 1 μg/mL) | 0.87 (0.77–0.97) | 0.01 | 0.88 (0.81–0.97) | <0.01 |
| Men | ||||
| Insulin (per 1 μiu/mL) | 1.01 (0.95–1.07) | 0.73 | 1.08 (1.02–1.15) | <0.01 |
| Adiponectin (per 1 μg/mL) | 0.61 (0.49–0.76) | <0.001 | 0.97 (0.90–1.05) | 0.48 |
BMI, body mass index; OR, odds ratio; CI, confidential interval.